Sign in
Active, not recruitingNo phase

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
3,000 people, planned
Started
28 Jan 2025
Expected to end
1 Aug 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mi Quit Care
Record updated
30 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • aged 18 years and older
  • current smoker
  • English speaking
  • Patient at Mile Square Health Center (Main, Englewood, South Shore, Auburn Gresham, Cicero, Back of the Yards)

Who cannot take part

  • aged less than 18
  • non-smoker
  • non English speaking
  • Not a patient at MSHC

Where in United States

  • University of Illinois at ChicagoChicago, United States

About the trial

What the trial wants to find out

The over-arching research question is: Does message (Advise) and referral approach (Refer) influence a patient's willingness to "opt-in" to receive a call from an Illinois Tobacco Quitline (ITQL) smoking cessation coach in patients at MSHC.

Read full original descriptionShow less

Primary UH3 study aim: Compare the effect of the portal-delivered Choice message (Arm 1) to the Information-only message (Arm 3) on linkage to the Illinois Tobacco Quitline (i.e., spoke to a Quitline coach).

Secondary UH3 aims are to:

Examine the reach of the patient portal for delivering "Advise" and "Refer" at 4 weeks. Reach is defined as a patient opening the portal-delivered provider message across all three Arms.

Compare the effect of the Quit message (Quit, Arm 2) to Information-only (Arm 3) on linkage to ITQL.

Compare the effect of the Facilitated-referral messages (opt-in link in the message: Arm 1 \& 2) vs. Self-referral (Information-only, Arm 3) on linkage to the ITQL (speaking to an ITQL coach) at four weeks.

Compare the effect of the portal-message content of the Choice message (Arm 1) vs. the Quit message (Arm 2) on linkage acceptance (opting in to be called by the ITQL) at 4 weeks.

Compare the effectiveness of re-engagement message 1 to message 2 for linkage to the ITQL among patients who opted-in to an ITQL call but who were not reached after 3 attempts.

Evaluate the cost-effectiveness of using a patient portal to advise patients to change their smoking behavior and refer them to the ITQL. We will compare the costs associated with our project to the costs associated with advising and referring patients during clinical appointments.

The 2 groups in the trial

  • MiQuit CareTreatment being tested

    Intervention arm: Advise to quit + automatic linkage to quitline + patient navigation

    Treatment: Mi Quit Care

  • Enhanced Standard of CareExisting treatment, for comparison

    Active Comparator: Advise to quit + written self-help materials

    Treatment: Mi Quit Care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
30 March 2026